Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stages II-III Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00365287
What this trial is testing

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Who this might be right for
Breast CancerKidney CancerLeukemia+3 more
Masonic Cancer Center, University of Minnesota 148
Testing effectiveness (Phase 2)Ended earlyNCT06617455
What this trial is testing

Fezolinetant for the Improvement of Vasomotor Symptoms in Breast Cancer Patients Taking Endocrine Therapy, VENT Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+2 more
University of Michigan Rogel Cancer Center 9
Early research (Phase 1)Looking for participantsNCT06324240
What this trial is testing

Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+24 more
Emory University 18
Not applicableLooking for participantsNCT06582615
What this trial is testing

Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Triple-Negative Breast Carcinoma
Ohio State University Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06353997
What this trial is testing

Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients

Who this might be right for
Triple Negative Breast Cancer
Providence Health & Services 12
Not applicableActive Not RecruitingNCT03786354
What this trial is testing

Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+12 more
Ohio State University Comprehensive Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00499083
What this trial is testing

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Who this might be right for
Breast Cancer
University of Nebraska 17
Not applicableStudy completedNCT01982591
What this trial is testing

Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Who this might be right for
Male Breast CancerNeurotoxicityPeripheral Neuropathy+6 more
Fox Chase Cancer Center 115
Large-scale testing (Phase 3)Active Not RecruitingNCT00433420
What this trial is testing

Combination Chemotherapy With or Without Fluorouracil and/or Pegfilgrastim in Treating Women With Node-Positive Breast Cancer

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00343512
What this trial is testing

Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 34
Very early researchUnknownNCT05828238
What this trial is testing

Positron Emission Tomograph(PET) Imaging Explores the Role of SF-DEVD-2 in Monitoring Tumor Efficacy

Who this might be right for
Breast Cancer Stage IIBreast Cancer Stage IIISolid Tumor
Affiliated Hospital of Jiangnan University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05455658
What this trial is testing

STEMVAC in Patients With Early Stage Triple Negative Breast Cancer

Who this might be right for
Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8+14 more
University of Washington 33
Testing effectiveness (Phase 2)Study completedNCT00004157
What this trial is testing

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Who this might be right for
Breast CancerGestational Trophoblastic TumorKidney Cancer+5 more
Fred Hutchinson Cancer Center
Not applicableUnknownNCT01612247
What this trial is testing

Low Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
University of Vermont 13
Large-scale testing (Phase 3)UnknownNCT01064635
What this trial is testing

Letrozole in Treating Breast Cancer in Postmenopausal Women With Stage I, II, or III Breast Cancer Previously Treated With Tamoxifen (GIM4)

Who this might be right for
Breast Cancer
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 2,056
Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Testing effectiveness (Phase 2)Study completedNCT00107510
What this trial is testing

Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 58
Testing effectiveness (Phase 2)Looking for participantsNCT07044310
What this trial is testing

5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss

Who this might be right for
Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8+2 more
Mayo Clinic 38
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Next Page